Dentsply Sirona (NASDAQ:XRAY) experienced a 7.5% decline in stock value due to concerns surrounding its upcoming Q2 2025 earnings report, which analysts expect to show a significant decline in revenue compared to the previous year, and the company's overall financial performance indicated by a negative net margin of 24.42% despite beating estimates in the last quarter.

Dentsply Sirona (NASDAQ:XRAY) experienced a 7

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) stock saw a modest increase of 0.25% recently, reflecting a consensus “Hold” rating from analysts, with some upgrades and target price adjustments, primarily driven by positive earnings results that exceeded expectations and a stable dividend announcement. 

The stock went up likely due to its recent earnings report, which outperformed analyst predictions, showcasing better-than-expected revenue and earnings per share.

DENTSPLY SIRONA Inc

DENTSPLY SIRONA (NASDAQ:XRAY) stock rose 2.68% following a substantial increase in institutional investment, including a 9.0% stake boost by Envestnet Asset Management and other large investors buying shares, indicating positive market sentiment and confidence in the company's potential growth despite recent mixed earnings results.

DENTSPLY SIRONA (NASDAQ:XRAY) stock rose 2

DENTSPLY SIRONA's stock (NASDAQ: XRAY) rose 2.68% as analysts reaffirmed its "hold" rating, while some elevated their ratings or targets, reflecting a mixed but generally positive outlook regarding the company's performance after reporting better-than-expected earnings and revenue results last quarter. 

The stock likely went up due to a combination of strong quarterly earnings that beat analyst expectations and supportive analyst upgrades, suggesting investor confidence in the company's potential despite recent mixed ratings.

DENTSPLY SIRONA's stock (NASDAQ: XRAY) rose 2

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) stock increased by 2.68% following a 9.0% rise in Envestnet Asset Management Inc.'s holdings during the first quarter and several other hedge funds increasing their positions in the company, indicating growing institutional confidence in the stock.

Dentsply Sirona (XRAY) announced the appointment of Daniel Scavilla as its new CEO, effective August 1, 2025, succeeding Simon Campion, which may have contributed to a slight decline of 0.32% in the stock as investors reacted to the leadership change and its implications for the company's future direction.

Dentsply Sirona (XRAY) announced the appointment of Daniel Scavilla as its new CEO, effective August

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) stock experienced a slight decline of 0.32% due to a combination of institutional investments and analysts lowering their price targets, despite reporting better-than-expected earnings.

Dentsply Sirona (NASDAQ:XRAY) stock decreased by 0.19% due to a mix of analyst rating adjustments and a significant year-over-year revenue decline of 7.8%, despite a positive earnings report exceeding analyst expectations.

Dentsply Sirona (NASDAQ:XRAY) stock decreased by 0

Dentsply Sirona's (NASDAQ: XRAY) stock declined by 0.69% due to the Bank of New York Mellon Corp reducing its stake in the company and negative sentiment from analysts following the company's recent earnings report, which showed a slight revenue decrease despite beating EPS estimates.

Dentsply Sirona's (NASDAQ: XRAY) stock declined by 0

DENTSPLY SIRONA (NASDAQ:XRAY) stock fell by 0.5% despite a recent upgrade to a "buy" rating from Wall Street Zen, primarily due to lowered price targets from multiple brokerages following a decline in revenue projections and the company reporting a negative net margin of 24.42% in their latest earnings report.

DENTSPLY SIRONA (NASDAQ:XRAY) stock fell by 0

Dentsply Sirona Inc. (NASDAQ:XRAY) stock recently dropped 1.3% following a challenging financial report highlighting a 7.7% revenue decline in Q1 2025 compared to the previous year and overall underperformance amidst investors favoring AI stocks with higher potential returns.

Dentsply Sirona Inc

Dentsply Sirona's stock (NASDAQ: XRAY) rose by 3.7% following positive quarterly earnings results that exceeded analyst expectations and was supported by significant institutional investor activity. The increase is primarily attributed to the company's stronger-than-expected earnings per share and revenue performance, alongside a recent dividend announcement.

Dentsply Sirona's stock (NASDAQ: XRAY) rose by 3

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) stock rose 0.6% as analysts generally maintain a "Hold" recommendation with a couple of upgrades to "Buy," coupled with positive earnings results that exceeded expectations, which likely contributed to the stock's upward movement.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) saw its stock rise by 4.16% due to a mix of institutional investors adjusting their holdings positively, strong quarterly earnings that exceeded analyst expectations, and a recently declared dividend, all contributing to growing confidence in the company.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) saw its stock decrease by 0.31%, attributed to a series of lowered price targets by analysts and a generally cautious market sentiment despite recent institutional investment activity.

DENTSPLY SIRONA (NASDAQ:XRAY) stock rose 2.3% due to increased institutional investment, with notable stakes acquired by Blue Trust Inc. and other hedge funds during the 1st quarter, alongside analysts raising price targets and maintaining a generally favorable outlook.

DENTSPLY SIRONA (NASDAQ:XRAY) stock fell by 0.62% as analysts have generally recommended a "Hold" rating, with recent downgrades of price targets and mixed earnings performance contributing to a cautious market outlook.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) shares fell by 1.83% due to Rhumbline Advisers reducing its stake in the company, alongside mixed analyst ratings and ongoing concerns about declining revenue despite exceeding earnings expectations.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) saw its stock rise by 1.11% due to increased institutional investment, including a recent stake purchase by Merit Financial Group and overall positive sentiment after the company reported better-than-expected earnings and revenue last quarter.

XRAY

Latest News & Analysis